# SunocoCorp LLC: financial statements, quarterly

SUNC · TXSE · CIK 2089661 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sunc.md) · [Financials](/companies/sunc/financials.md) · [Filings](/companies/sunc/filings.md) · [Insiders](/companies/sunc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sunc/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $bn | [5.2](/filings/0002089661-26-000033.md) | [5.4](/filings/0002089661-26-000049.md) | [10.7](/filings/0002089661-26-000033.md) | [14.3](/filings/0002089661-26-000049.md) |
| Cost of revenue | $bn | [4.5](/filings/0002089661-26-000033.md) | [4.8](/filings/0002089661-26-000049.md) | [9.0](/filings/0002089661-26-000033.md) | [12.8](/filings/0002089661-26-000049.md) |
| Operating income | $bn | [0.3](/filings/0002089661-26-000033.md) | [0.2](/filings/0002089661-26-000049.md) | [0.9](/filings/0002089661-26-000033.md) | [0.6](/filings/0002089661-26-000049.md) |
| Interest expense | $bn | [0.1](/filings/0002089661-26-000033.md) | [0.1](/filings/0002089661-26-000049.md) | [0.2](/filings/0002089661-26-000033.md) | [0.2](/filings/0002089661-26-000049.md) |
| Income tax | $bn | [(0.0)](/filings/0002089661-26-000033.md) | [0.0](/filings/0002089661-26-000049.md) | [0.1](/filings/0002089661-26-000033.md) | [0.1](/filings/0002089661-26-000049.md) |
| Net income | $bn | [0.0](/filings/0002089661-26-000033.md) | [0.0](/filings/0002089661-26-000049.md) | [0.1](/filings/0002089661-26-000033.md) | [0.0](/filings/0002089661-26-000049.md) |
| Diluted EPS | $ per share | not reported | not reported | [2.13](/filings/0002089661-26-000033.md) | [0.76](/filings/0002089661-26-000049.md) |
| Basic EPS | $ per share | not reported | not reported | [2.14](/filings/0002089661-26-000033.md) | [0.76](/filings/0002089661-26-000049.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0002089661-26-000016.md) | [0.9](/filings/0002089661-26-000016.md) | not reported | not reported |
| Current assets | $bn | [2.5](/filings/0002089661-26-000016.md) | [5.5](/filings/0002089661-26-000049.md) | [6.8](/filings/0002089661-26-000033.md) | [6.8](/filings/0002089661-26-000049.md) |
| Total assets | $bn | [14.4](/filings/0002089661-26-000016.md) | [28.4](/filings/0002089661-26-000049.md) | [30.3](/filings/0002089661-26-000033.md) | [29.9](/filings/0002089661-26-000049.md) |
| Current liabilities | $bn | [1.9](/filings/0002089661-26-000016.md) | [4.0](/filings/0002089661-26-000049.md) | [4.9](/filings/0002089661-26-000033.md) | [5.3](/filings/0002089661-26-000049.md) |
| Total liabilities | $bn | [10.3](/filings/0002089661-26-000016.md) | [20.3](/filings/0002089661-26-000049.md) | [21.9](/filings/0002089661-26-000033.md) | [21.6](/filings/0002089661-26-000049.md) |
| Long-term debt | $bn | [7.5](/filings/0002089661-26-000016.md) | [13.4](/filings/0002089661-26-000016.md) | not reported | not reported |
| Current portion of debt | $bn | not reported | [0.0](/filings/0002089661-26-000049.md) | [0.0](/filings/0002089661-26-000033.md) | [0.0](/filings/0002089661-26-000049.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [156](/filings/0002089661-26-000033.md) | [243 d](/filings/0002089661-26-000049.md) | [454](/filings/0002089661-26-000033.md) | [1,101 d](/filings/0002089661-26-000049.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [51.5](/filings/0002089661-26-000033.md) | [51.6](/filings/0002089661-26-000049.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 51,517,198 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0002089661-26-000049.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.